Beyond weight loss and glucose control, how do you see GLP-1 agonists being leveraged to treat other conditions, such as cardiovascular disease, chronic kidney disease, sleep apnea, or osteoarthritis
This skincare workhorse flattens nasty bumps while fading depressions over time
Elevated apolipoprotein E expression in hippocampal microglia drives temporal lobe epilepsy progression
Large-scale projects such as The Cancer Genome Atlas (TCGA) (270), Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) (271), International cancer genome Consortium (ICGC) (272), Pan Cancer Analysis of Whole Genome (PCAWG) (273), National Cancer Institute-Clinical Proteomic Tumor Analysis Consortium (NCI-CPTAC) (274), and Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) (275) have generated high-resolution datasets that include bulk gene expression data, somatic mutations, Copy Number Variations (CNVs), methylation patterns, cell-type-specific gene expression profiles, acetylation, and phosphorylation across thousands of samples collected from diverse races and geographical locations